Targeted Lymphoma Drug Works After Others Fail

submitted by: mdanderson

MD Anderson's Dr. Michelle Fanale, Hodgkin lymphoma survivor Alexandra Medina and research nurse Rinata Simien talk about newly approved drug brentuximab vedotin.

DIRICOM Research Project

submitted by: neo

This video presents the DIRICOM Research Project. One of the goals inside this Project is to design a wireless system network that allows the communication among cars (the so-called Vehicular Ad-hoc Network or VANETs). For more information, please visit: DIRICOM web site

iDASH Internship Symposium Welcome

submitted by: ucsd_idash

iDASH Internship Symposium Welcome by Dr. Lucila Ohno Machado.

Hope on the Horizon for Pancreatic Cancer Patients

submitted by: mdanderson
Clinical Trial: http://1.usa.gov/PncreasCncr Milind Javle, M.D., associate professor in the Department of Gastrointestinal Medical Oncology at MD Anderson Cancer Center, is offering hope for those faced with pancreatic cancer. Javle is leading a new clinical trial which targets the rapid growth of pancreatic cancer cells. This trial is testing the standard treatment with a new antibody that has shown promising results in the laboratory. Javle says it is believed that every pancreatic...

'GlyphSea': A New Way to Visualize Vector Data

submitted by: btolo

Researchers at the San Diego Supercomputer Center (SDSC) and other organizations within the University of California, San Diego, have developed a novel way to encode and display vector data that clearly shows magnitude and direction. This new visualization technique may help seismologists to accurately analyze ground movements for an earthquake, measure magnetic turbulence in deep space, or allow medical researchers to study areas such as blood flow and nutrient absorption.

Antibiotic resistant hospital bacteria

submitted by: COMED2010
MOSAR aims to significantly advance our knowledge regarding the control of antimicrobial resistance of bacteria responsible for major and emerging nosocomial diseases in hospitals, which are now spreading into communities. MOSAR will examine the factors determining the dynamics of spread of AMRB within healthcare facilities and the relative efficacity and medicoeconomic impact of control strategies. The resulting new knowledge will be disseminated to caregivers and health policy makers and...

Intestinal microbiota and human health

submitted by: COMED2010
The central objective of the MetaHit project is to establish associations between the genes of the human intestinal microbiota and human health and disease. The research work is focused on two disorders of increasing importance in Europe, Inflamatory Bowel Disease (IBD) and obesity. First, we need to establish an extensive reference catalog of microbial genes and genomes present in the human intestine. The second challenge is to develop tools to determine which genes and genomes of the...

How to define human biological age

submitted by: COMED2010
Towards establishing biomarkers of human ageing “European Study to Establish Biomarkers of Human Ageing (MARK-AGE)” brings together 26 groups located in 14 European countries. The scientific background is the following: The rate of ageing in humans is not uniform, age-related changes in body function or composition that could serve as a measure of “biological” age and predict the onset of age-related diseases and/or residual lifetime are termed “biomarkers of ageing”. Within the...

Dogs help to decode human DNA

submitted by: COMED2010
Dogs are more than man’s best friends; they can help us unravelling the genetic of diseases such as cancer, epilepsy, cardiovascular troubles, diabetes etc. Living in the same environment human and dogs are suffering from the same diseases but the genetic complexity is quite lower in dogs. During 4 years 20 veterinary schools spread across Europe are working together to collect 10.000 blood samples from purebred dogs affected by similar diseases as human. The analysis of the genome of...

New heart valve development for children

submitted by: COMED2010
The general objective of the LifeValve project is to develop a new therapeutic strategy to treat heart valve disease. In particular, the development of a tissue engineered living heart valve, with the capacity of growth in accordance with the growths of children, which can be implanted without an operation by minimally invasive catheter technology will be addressed. The rationale for first focussing on paediatric applications is twofold: First, a novel, tissue engineered living heart valve...